Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial.
Grainger JD, Locatelli F, Chotsampancharoen T, Donyush E, Pongtanakul B, Komvilaisak P, Sosothikul D, Drelichman G, Sirachainan N, Holzhauer S, Lebedev V, Lemons R, Pospisilova D, Ramenghi U, Bussel JB, Bakshi KK, Iyengar M, Chan GW, Chagin KD, Theodore D, Marcello LM, Bailey CK. Grainger JD, et al. Among authors: sosothikul d. Lancet. 2015 Oct 24;386(10004):1649-58. doi: 10.1016/S0140-6736(15)61107-2. Epub 2015 Jul 28. Lancet. 2015. PMID: 26231455 Clinical Trial.
Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: a prospective multicenter study.
Rujkijyanont P, Photia A, Traivaree C, Monsereenusorn C, Anurathapan U, Seksarn P, Sosothikul D, Techavichit P, Sanpakit K, Phuakpet K, Wiangnon S, Chotsampancharoen T, Chainansamit SO, Kanjanapongkul S, Meekaewkunchorn A, Hongeng S. Rujkijyanont P, et al. Among authors: sosothikul d. BMC Cancer. 2019 Oct 16;19(1):961. doi: 10.1186/s12885-019-6186-z. BMC Cancer. 2019. PMID: 31619207 Free PMC article.
Pediatric primary central nervous system tumors registry in Thailand under National Health Security Office schemes.
Pongtanakul B, Sirachainan N, Surapolchai P, Charoenkwan P, Choeyprasert W, Komwilaisak P, Chainansamit SO, Witsanuyothin N, Lertrakul Y, Rujkijyanont P, Kanjanapongkul S, Sosothikul D, Sanpakit K, Chotsampancharoen T, Wangruangsathit S, Thokanit NS, Tabjareon S, Hongeng S. Pongtanakul B, et al. Among authors: sosothikul d. J Neurooncol. 2020 Aug;149(1):141-151. doi: 10.1007/s11060-020-03582-w. Epub 2020 Jul 24. J Neurooncol. 2020. PMID: 32710301
MYH9 disorder: Identification and a novel mutation in patients with macrothrombocytopenia.
Natesirinilkul R, Sosothikul D, Komwilaisak P, Pongtanakul B, Narkbunnum N, Yudhasompop N, Mekjarusgool P, Niparuck P, Boonyawat K, Kunishima S, Sirachainan N; Thai Macrothrombocytopenia Study Group. Natesirinilkul R, et al. Among authors: sosothikul d. Pediatr Blood Cancer. 2021 Jul;68(7):e29055. doi: 10.1002/pbc.29055. Epub 2021 Apr 15. Pediatr Blood Cancer. 2021. PMID: 33855781
Genetic variations of type 2 and type 3 von Willebrand diseases in Thailand.
Lauhasurayotin S, Moonla C, Ittiwut R, Ittiwut C, Songthawee N, Komvilaisak P, Natesirinilkul R, Sirachainan N, Rojnuckarin P, Sosothikul D, Suphapeetiporn K. Lauhasurayotin S, et al. Among authors: sosothikul d. J Clin Pathol. 2023 Nov 22:jcp-2023-209123. doi: 10.1136/jcp-2023-209123. Online ahead of print. J Clin Pathol. 2023. PMID: 38053262
National strategic advocacy to manage patients with inherited bleeding disorders in low and lower-middle income countries.
Chuansumrit A, Ruchutrakul T, Sirachainan N, Kitpoka P, Panuwannakorn M, Panburana P, Suwannuraks M, Sri-Udomporn N, Kijkunasathian C, Jaovisidha S, Utamakul C, Natesirinilkul R, Pongtanakul B, Traivaree C, Komvilaisak P, Suwantaroj E, Sosothikul D, Angchaisuksiri P, Rojnuckarin P. Chuansumrit A, et al. Among authors: sosothikul d. Expert Rev Hematol. 2023 Jul-Dec;16(12):1063-1076. doi: 10.1080/17474086.2023.2293092. Epub 2023 Dec 18. Expert Rev Hematol. 2023. PMID: 38100503 Review.
Cost and effectiveness comparison of sirolimus versus standard treatment in Kasabach-Merritt phenomenon: a real-world evidence study in Thailand.
Tongruang C, Wananukul S, Chatproedprai S, Narkbunnam N, Nitiyarom R, Sirachainan N, Natesirinilkul R, Chaweephisal P, Sosothikul D. Tongruang C, et al. Among authors: sosothikul d. Pediatr Hematol Oncol. 2024 Apr;41(3):229-239. doi: 10.1080/08880018.2023.2300485. Epub 2024 Jan 18. Pediatr Hematol Oncol. 2024. PMID: 38235681
Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial.
Halton J, Brandão LR, Luciani M, Bomgaars L, Chalmers E, Mitchell LG, Nurmeev I, Sharathkumar A, Svirin P, Gorbatikov K, Tartakovsky I, Simetzberger M, Huang F, Sun Z, Kreuzer J, Gropper S, Reilly P, Brueckmann M, Albisetti M; DIVERSITY Trial Investigators. Halton J, et al. Lancet Haematol. 2021 Jan;8(1):e22-e33. doi: 10.1016/S2352-3026(20)30368-9. Epub 2020 Dec 5. Lancet Haematol. 2021. PMID: 33290737 Clinical Trial.
Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children.
Brandão LR, Albisetti M, Halton J, Bomgaars L, Chalmers E, Mitchell LG, Nurmeev I, Svirin P, Kuhn T, Zapletal O, Tartakovsky I, Simetzberger M, Huang F, Sun Z, Kreuzer J, Gropper S, Brueckmann M, Luciani M; DIVERSITY Study Investigators. Brandão LR, et al. Blood. 2020 Feb 13;135(7):491-504. doi: 10.1182/blood.2019000998. Blood. 2020. PMID: 31805182 Free PMC article. Clinical Trial.
62 results